Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Dementia Treatment Market

Dementia Treatment Market Size

  • Report ID: GMI9342
  • Published Date: May 2024
  • Report Format: PDF

Dementia Treatment Market Size

Dementia Treatment Market size was valued at USD 17.7 billion in 2023 and is expected to exhibit growth at a CAGR of 7.6% from 2024 – 2032. High market growth can be attributed to the ongoing advancements in medical research, increasing prevalence of dementia, rising geriatric population, and growing demand for multimodal and personalized therapies, among other contributing factors.

 

Moreover, the global population is aging rapidly, with a significant increase in the proportion of older adults. Aging is the primary risk factor for dementia, and as the population ages, the prevalence of dementia is expected to rise. For instance, according to a recent United Nations (UN) research report, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population.
 

This demographic trend creates a growing market for dementia treatments as the demand for effective therapies to manage symptoms and improve quality of life increases.
 

Dementia treatment refers to a broad range of therapeutic interventions aimed at managing the symptoms, slowing the progression, and improving the quality of life of individuals diagnosed with dementia. Dementia is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, impaired reasoning, and changes in behavior and personality.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The dementia treatment market was valued at USD 17.7 billion in 2023 and is expected to exhibit growth at 7.6% CAGR from 2024

The cholinesterase inhibitors segment in the dementia treatment industry generated USD 8 billion in 2023, owing to ongoing research efforts focused on improving the efficacy, safety, and tolerability of ChEIs.

North America dementia treatment market size was USD 6.7 billion in 2023 and is anticipated to grow at 7.4% CAGR between 2024

AbbVie Inc., Biogen, Cipla Inc., Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Sun Pharmaceutical Industries Ltd., Eli Lilly and Company, Merck & Co., Inc., Novartis AG and Otsuka Pharmaceutical Co., Ltd.

Dementia Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 150
  • Countries covered: 23
  • Pages: 110
 Download Free Sample